September 2023

As lending markets get tighter and the only certain thing on the horizon is uncertainty, advisers are sharpening their pencils to put a value on businesses. In this month’s cover story David Prosser looks at how sellers and buyers strike a price. Pharma, medical and biotech M&A is in the spotlight and we look at deals and the corporate finance network in the South West. We also profile the senior corporate finance professionals who became members of the faculty board this summer.

shapeshifting purple shapes mirrors sand desert ICAEW Corporate Financier M&A valuations

long read

Views on valuations

M&A is facing many challenges at present. To complete a deal, vendor and acquirer need to agree on a price. David Prosser speaks to investors and advisers about the different ways in which valuation can be viewed.

News and views

Faculty news

September 2023

This year’s Annual Reception, the new ‘Earn-outs in Deals’ guideline, and the Future of UK Capital Markets Regulation Summit.

opinion

Jon Moulton on pensions and PE

Will recent pledges from pension funds to allocate cash to private equity achieve anything, asks Jon Moulton.

Connections

Corporate finance advisory

Promotions and those on the move in corporate finance advisory.

Legal advisory

Who’s on the move or been promoted in legal advisory.

Private equity

Recruitment and promotions in private equity.

Innovation and sustainable recovery

Roadshow: South West

It’s been a subdued period for M&A activity in the South West, but advisers can now see clouds clearing as a raft of new regional funding becomes available. Andy Thomson reports.

Trendwatch: Pharma, medical and biotech M&A

Solid long-term growth drivers have seen the pharma, medical and biotech sector navigate choppy M&A markets better than other industries. Nicholas Neveling looks at the longer-term prognosis.

petri dish blood sample hand glove science test lab health pharma medical ICAEW Corporate Financier M&A healthcare

Insider dealing: APEM secures £50m+ funding

Environmental, social and governance (ESG) is on the agenda of all businesses now, and it’s the E in ESG that APEM, which in June took on another round of funding, is focused on. Jason Sinclair reports.